Article
Distinct role of the Fas rs1800682 and FasL rs763110 polymorphisms in determining the risk of breast cancer among Han Chinese females.
Drug design, development and therapy - 1 Jan 2016
Wang Meng, Wang Zheng, Wang Xi-Jing, Jin Tian-Bo, Dai Zhi-Ming, Kang Hua-Feng, Guan Hai-Tao, Ma Xiao-Bin, Liu Xing-Han, Dai Zhi-Jun
Abstract excerpt
BACKGROUND: In recent years, studies have demonstrated that polymorphisms in the promoters of Fas and FasL are significantly associated with breast cancer risk. However, the results of these studies were inconsistent. This case-control study was performed to explore the associations between Fas rs1800682 and FasL rs763110 polymorphisms and breast cancer. MATERIALS AND METHODS: A hospital-based case-control study...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
